This inventor holds 1 USPTO granted patent and 1 published patent application, plus 2 CIPO patents. Top assignees: Janssen Pharmaceutica Nv, Protagonist Therapeutics, Inc.. Active years: 2024.
Company Filing History:
1 out of 2,099 
1 out of 35 
Years Active: 2024
Title: Innovations of Mohammad Masjedizadeh
Introduction
Mohammad Masjedizadeh is an accomplished inventor based in Newark, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic compositions.
Latest Patents
Masjedizadeh holds 1 patent for his invention titled "Compositions of peptide inhibitors of Interleukin-23 receptor." This invention relates to compositions of peptide inhibitors of the interleukin-23 receptor (IL-23R) or pharmaceutically acceptable salt or solvate forms thereof. It includes corresponding pharmaceutical compositions, methods, and uses for the treatment of autoimmune inflammation and related diseases and disorders.
Career Highlights
Throughout his career, Masjedizadeh has worked with notable companies such as Janssen Pharmaceutica NV and Protagonist Therapeutics, Inc. His work in these organizations has contributed to advancements in therapeutic solutions.
Collaborations
Some of his coworkers include Giustino Di Pretoro and Dajun Sun. Their collaborative efforts have further enhanced the research and development in their respective fields.
Conclusion
Mohammad Masjedizadeh's innovative work in peptide inhibitors showcases his dedication to advancing medical treatments for autoimmune conditions. His contributions are valuable to the scientific community and the development of effective therapies.